Asia-Pacific Preventable Vaccines Market Report 2017

November 2017 | 128 pages | ID: A40A2584518EN
QYResearch

Abstracts

In this report, the Asia-Pacific Preventable Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Preventable Vaccines for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Preventable Vaccines market competition by top manufacturers/players, with Preventable Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Sanofi
• Takeda Pharmaceutical
• Abbott
• Roche
• AstraZeneca
• Mitsubishi Tanabe Pharma
• Lupin
• Serum Institute of India
• LG Life Sciences
• S K Chemicals
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Janssen Pharmaceuticals
• Crucell
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Dynavax
• Valeant Pharmaceuticals
• Protein Sciences
• Panacea Biotec

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Adult Preventable Vaccines
• Pediatric Preventable Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bacterial Diseases
• Virus Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Preventable Vaccines Market Report 2017

1 PREVENTABLE VACCINES OVERVIEW

1.1 Product Overview and Scope of Preventable Vaccines
1.2 Classification of Preventable Vaccines by Product Category
  1.2.1 Asia-Pacific Preventable Vaccines Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Preventable Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Adult Preventable Vaccines
  1.2.4 Pediatric Preventable Vaccines
1.3 Asia-Pacific Preventable Vaccines Market by Application/End Users
  1.3.1 Asia-Pacific Preventable Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Bacterial Diseases
  1.3.3 Virus Diseases
1.4 Asia-Pacific Preventable Vaccines Market by Region
  1.4.1 Asia-Pacific Preventable Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Preventable Vaccines (2012-2022)
  1.5.1 Asia-Pacific Preventable Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Preventable Vaccines Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PREVENTABLE VACCINES COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Preventable Vaccines Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Preventable Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Preventable Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Preventable Vaccines (Volume and Value) by Type
  2.2.1 Asia-Pacific Preventable Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Preventable Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Preventable Vaccines (Volume) by Application
2.4 Asia-Pacific Preventable Vaccines (Volume and Value) by Region
  2.4.1 Asia-Pacific Preventable Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Preventable Vaccines Revenue and Market Share by Region (2012-2017)

3 CHINA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 China Preventable Vaccines Sales and Value (2012-2017)
  3.1.1 China Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Preventable Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 China Preventable Vaccines Sales Price Trend (2012-2017)
3.2 China Preventable Vaccines Sales Volume and Market Share by Type
3.3 China Preventable Vaccines Sales Volume and Market Share by Application

4 JAPAN PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Preventable Vaccines Sales and Value (2012-2017)
  4.1.1 Japan Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Preventable Vaccines Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Preventable Vaccines Sales Price Trend (2012-2017)
4.2 Japan Preventable Vaccines Sales Volume and Market Share by Type
4.3 Japan Preventable Vaccines Sales Volume and Market Share by Application

5 SOUTH KOREA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Preventable Vaccines Sales and Value (2012-2017)
  5.1.1 South Korea Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Preventable Vaccines Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Preventable Vaccines Sales Price Trend (2012-2017)
5.2 South Korea Preventable Vaccines Sales Volume and Market Share by Type
5.3 South Korea Preventable Vaccines Sales Volume and Market Share by Application

6 TAIWAN PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Preventable Vaccines Sales and Value (2012-2017)
  6.1.1 Taiwan Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Preventable Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Preventable Vaccines Sales Price Trend (2012-2017)
6.2 Taiwan Preventable Vaccines Sales Volume and Market Share by Type
6.3 Taiwan Preventable Vaccines Sales Volume and Market Share by Application

7 INDIA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 India Preventable Vaccines Sales and Value (2012-2017)
  7.1.1 India Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Preventable Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 India Preventable Vaccines Sales Price Trend (2012-2017)
7.2 India Preventable Vaccines Sales Volume and Market Share by Type
7.3 India Preventable Vaccines Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Preventable Vaccines Sales and Value (2012-2017)
  8.1.1 Southeast Asia Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Preventable Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Preventable Vaccines Sales Price Trend (2012-2017)
8.2 Southeast Asia Preventable Vaccines Sales Volume and Market Share by Type
8.3 Southeast Asia Preventable Vaccines Sales Volume and Market Share by Application

9 AUSTRALIA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Preventable Vaccines Sales and Value (2012-2017)
  9.1.1 Australia Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Preventable Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Preventable Vaccines Sales Price Trend (2012-2017)
9.2 Australia Preventable Vaccines Sales Volume and Market Share by Type
9.3 Australia Preventable Vaccines Sales Volume and Market Share by Application

10 ASIA-PACIFIC PREVENTABLE VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 GlaxoSmithKline
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Preventable Vaccines Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Merck
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Preventable Vaccines Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Novartis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Preventable Vaccines Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Preventable Vaccines Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Preventable Vaccines Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Takeda Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Preventable Vaccines Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Abbott
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Preventable Vaccines Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Roche
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Preventable Vaccines Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 AstraZeneca
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Preventable Vaccines Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Mitsubishi Tanabe Pharma
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Preventable Vaccines Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Lupin
10.12 Serum Institute of India
10.13 LG Life Sciences
10.14 S K Chemicals
10.15 Shenzhen Kangtai Biological Products
10.16 Sinovac Biotech
10.17 Janssen Pharmaceuticals
10.18 Crucell
10.19 Bavarian Nordic
10.20 Baxter
10.21 Bharat Biotech
10.22 Dynavax
10.23 Valeant Pharmaceuticals
10.24 Protein Sciences
10.25 Panacea Biotec

11 PREVENTABLE VACCINES MANUFACTURING COST ANALYSIS

11.1 Preventable Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Preventable Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Preventable Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Preventable Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PREVENTABLE VACCINES MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Preventable Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Preventable Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Preventable Vaccines Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Preventable Vaccines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Preventable Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Preventable Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Preventable Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Preventable Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Preventable Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Preventable Vaccines Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Preventable Vaccines Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Preventable Vaccines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Preventable Vaccines Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Preventable Vaccines
Figure Asia-Pacific Preventable Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Preventable Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Adult Preventable Vaccines Product Picture
Figure Pediatric Preventable Vaccines Product Picture
Figure Asia-Pacific Preventable Vaccines Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Preventable Vaccines by Application in 2016
Figure Bacterial Diseases Examples
Table Key Downstream Customer in Bacterial Diseases
Figure Virus Diseases Examples
Table Key Downstream Customer in Virus Diseases
Figure Asia-Pacific Preventable Vaccines Market Size (Million USD) by Region (2012-2022)
Figure China Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Preventable Vaccines Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Preventable Vaccines Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Preventable Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Preventable Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Preventable Vaccines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Preventable Vaccines Sales Share by Players/Suppliers
Figure Asia-Pacific Preventable Vaccines Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Preventable Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Preventable Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Preventable Vaccines Revenue Share by Players
Figure 2017 Asia-Pacific Preventable Vaccines Revenue Share by Players
Table Asia-Pacific Preventable Vaccines Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Preventable Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Preventable Vaccines by Type (2012-2017)
Figure Asia-Pacific Preventable Vaccines Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Preventable Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Preventable Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Type (2012-2017)
Figure Asia-Pacific Preventable Vaccines Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Preventable Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Preventable Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Preventable Vaccines by Region (2012-2017)
Figure Asia-Pacific Preventable Vaccines Sales Market Share by Region in 2016
Table Asia-Pacific Preventable Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Preventable Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Region (2012-2017)
Figure Asia-Pacific Preventable Vaccines Revenue Market Share by Region in 2016
Table Asia-Pacific Preventable Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Preventable Vaccines Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Preventable Vaccines Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Preventable Vaccines Sales Market Share by Application (2012-2017)
Figure China Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure China Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table China Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table China Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China Preventable Vaccines Sales Volume Market Share by Type in 2016
Table China Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table China Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure Japan Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Japan Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan Preventable Vaccines Sales Volume Market Share by Type in 2016
Table Japan Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Japan Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure South Korea Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table South Korea Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure South Korea Preventable Vaccines Sales Volume Market Share by Type in 2016
Table South Korea Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure South Korea Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure Taiwan Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Preventable Vaccines Sales Volume Market Share by Type in 2016
Table Taiwan Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure India Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure India Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table India Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table India Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India Preventable Vaccines Sales Volume Market Share by Type in 2016
Table India Preventable Vaccines Sales Volume (K Units) by Application (2012-2017)
Table India Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Preventable Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Preventable Vaccines Sales Volume Market Share by Application in 2016
Figure Australia Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Preventable Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Preventable Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Australia Preventable Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Australia Preventable Vaccines Sales Volume Market Share by Type in 2016
Table Australia Preventable Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Australia Preventable Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Australia Preventable Vaccines Sales Volume Market Share by Application in 2016
Table GlaxoSmithKline Preventable Vaccines Basic Information List
Table GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Preventable Vaccines Basic Information List
Table Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Preventable Vaccines Basic Information List
Table Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Preventable Vaccines Basic Information List
Table Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Preventable Vaccines Basic Information List
Table Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Takeda Pharmaceutical Preventable Vaccines Basic Information List
Table Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Preventable Vaccines Basic Information List
Table Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Preventable Vaccines Basic Information List
Table Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca Preventable Vaccines Basic Information List
Table AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Mitsubishi Tanabe Pharma Preventable Vaccines Basic Information List
Table Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Lupin Preventable Vaccines Basic Information List
Table Serum Institute of India Preventable Vaccines Basic Information List
Table LG Life Sciences Preventable Vaccines Basic Information List
Table S K Chemicals Preventable Vaccines Basic Information List
Table Shenzhen Kangtai Biological Products Preventable Vaccines Basic Information List
Table Sinovac Biotech Preventable Vaccines Basic Information List
Table Janssen Pharmaceuticals Preventable Vaccines Basic Information List
Table Crucell Preventable Vaccines Basic Information List
Table Bavarian Nordic Preventable Vaccines Basic Information List
Table Baxter Preventable Vaccines Basic Information List
Table Bharat Biotech Preventable Vaccines Basic Information List
Table Dynavax Preventable Vaccines Basic Information List
Table Valeant Pharmaceuticals Preventable Vaccines Basic Information List
Table Protein Sciences Preventable Vaccines Basic Information List
Table Panacea Biotec Preventable Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Preventable Vaccines
Figure Manufacturing Process Analysis of Preventable Vaccines
Figure Preventable Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Preventable Vaccines Major Manufacturers in 2016
Table Major Buyers of Preventable Vaccines
Table Distributors/Traders List
Figure Asia-Pacific Preventable Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Preventable Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Preventable Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Preventable Vaccines Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Preventable Vaccines Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Preventable Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Preventable Vaccines Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Preventable Vaccines Revenue Market Share Forecast by Region in 2022
Figure China Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Preventable Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Preventable Vaccines Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Preventable Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Preventable Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Preventable Vaccines Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Preventable Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Preventable Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources